Table 1.
Demographic summary of NEER and PCAWG subset
| NEER | PCAWG | |
|---|---|---|
| N | 51 | 414 |
| Male, n(%) | 20 (39.2%) | 154 (37.2%) |
| Age, median (IQR) | 66 [62,70] | 62 [51,71] |
| Organ System, n(%) | ||
| Breast | 13 (25.5%) | 106 (25.6%) |
| Pancreas | 7 (13.7%) | 57 (13.8%) |
| Lung | 5 (9.8%) | 41 (9.9%) |
| Leukemia | 4 (7.8%) | 33 (8.0%) |
| Ovary | 4 (7.8%) | 33 (8.0%) |
| Kidney | 3 (5.9%) | 24 (5.8%) |
| Uterus | 3 (5.9%) | 24 (5.8%) |
| Brain | 2 (3.9%) | 16 (3.9%) |
| Intestine | 2 (3.9%) | 16 (3.9%) |
| Melanoma | 2 (3.9%) | 16 (3.9%) |
| Bladder | 1 (2.0%) | 8 (1.9%) |
| Bone | 1 (2.0%) | 8 (1.9%) |
| Esophagus or Stomach | 1 (2.0%) | 8 (1.9%) |
| Gallbladder or Liver | 1 (2.0%) | 8 (1.9%) |
| Prostate | 1 (2.0%) | 8 (1.9%) |
| Thyroid | 1 (2.0%) | 8 (1.9%) |
| Cancer Stage, n(%) | ||
| Binet A | 0 (0.0%) | 18 (4.3%) |
| Binet B | 0 (0.0%) | 4 (1.0%) |
| Binet C | 1 (2.0%) | 2 (0.5%) |
| I | 0 (0.0%) | 42 (10.1%) |
| II | 0 (0.0%) | 59 (14.3%) |
| III | 2 (3.9%) | 31 (7.5%) |
| IV | 43 (84.3%) | 3 (0.7%) |
| NA | 5 (9.8%) | 225 (61.6%) |
| Vital Status, n(%) | ||
| Alive | 47 (92.2%) | 266 (64.3%) |
| Deceased | 4 (7.8%) | 126 (30.4%) |
| NA | 22 (5.3%) | |
| Years survived (censored), median (IQR) | 12.77 [9.01,18.04] | 2.89 [1.35,5.21] |